Kobayashi Hiroshi, Ariga Masamichi, Sato Yohei, Fujiwara Masako, Fukasawa Nei, Fukuda Takahiro, Takahashi Hiroyuki, Ikegami Masahiro, Kosuga Motomichi, Okuyama Torayuki, Eto Yoshikatsu, Ida Hiroyuki
Division of Gene Therapy, Research Center of Medical Sciences, Jikei University School of Medicine, Tokyo, Japan.
Department of Pediatrics, Jikei University School of Medicine, Tokyo, Japan.
JIMD Rep. 2018;41:101-107. doi: 10.1007/8904_2018_106. Epub 2018 Apr 29.
We report an autopsy case of a woman with mucopolysaccharidosis type I (MPS I) Hurler-Scheie syndrome who was treated with enzyme replacement therapy (ERT) for 12 years. This was the first case of MPS I treated with ERT in Japan. Pathological analysis showed no glycosaminoglycan accumulation in the liver and spleen as a result of long-term ERT, although severe aortic stenosis, diffuse intimal hyperplasia of the coronary artery, and fibrous hypertrophy of the endocardium were observed. Additionally, we detected subunit c mitochondrial ATP synthase (SCMAS) accumulation and mild tauopathy (hyperphosphorylated tau or p-tau, both 3-repeat and 4-repeat tau accumulation) in the same area of the cerebral limbic system and central gray matter of the mid brain and pons. Tauopathy is an important pathological finding in Alzheimer's disease and other neurodegenerative disorders; however, in MPS I, it is unclear whether tauopathy is a primary or secondary phenomenon. Thus, in this report, we describe pathological accumulation of p-tau and SCMAS in the context of MPS I and discuss the mechanisms and importance of these findings in the pathogenesis of MPS I.
我们报告了一例黏多糖贮积症I型(MPS I)Hurler-Scheie综合征女性患者的尸检病例,该患者接受了12年的酶替代疗法(ERT)。这是日本首例接受ERT治疗的MPS I病例。病理分析显示,长期ERT治疗后肝脏和脾脏未出现糖胺聚糖蓄积,尽管观察到严重的主动脉瓣狭窄、冠状动脉弥漫性内膜增生以及心内膜纤维性肥厚。此外,我们在大脑边缘系统以及中脑和脑桥的中央灰质的同一区域检测到亚基c线粒体ATP合酶(SCMAS)蓄积和轻度tau蛋白病(过度磷酸化tau或p-tau,3重复和4重复tau均蓄积)。Tau蛋白病是阿尔茨海默病和其他神经退行性疾病的重要病理表现;然而,在MPS I中,尚不清楚tau蛋白病是原发性还是继发性现象。因此,在本报告中,我们描述了MPS I背景下p-tau和SCMAS的病理蓄积,并讨论了这些发现在MPS I发病机制中的机制和重要性。